Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.81 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.65 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.65 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.64 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.60 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.60 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.60 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.60 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.60 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.60 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.60 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.60 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.60 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.60 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.60 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.58 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6553283 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 | |
| SCHEMBL6372057 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 | |
| SCHEMBL6372065 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 | |
| SCHEMBL17204255 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 | |
| SCHEMBL9666121 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 | |
| SCHEMBL22494096 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 | |
| SCHEMBL22494095 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 | |
| SCHEMBL21998924 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 | |
| SCHEMBL22494097 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 | |
| SCHEMBL9716614 | 1.00 | FAAH (0.81) | FAAHITGB3ITGA2BPSMB5HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117643709-A | Antifreezing fire water evaporation-proof crystallization inhibitor and preparation method thereof | 陕西交通控股集团有限公司宜富分公司 | 2024-03-05 | — | — | CN | claimed |
| US-11485891-B2 | Products and methods for the treatment of mixtures of water and hydrophobic liquids | B.C. RESEARCH INC. (CA) | 2022-11-01 | — | — | US | claimed |
| US-20210230466-A1 | PRODUCTS AND METHODS FOR THE TREATMENT OF MIXTURES OF WATER AND HYDROPHOBIC LIQUIDS | B.C. RESEARCH INC. (CA) | 2021-07-29 | — | — | US | claimed |
| WO-2019232629-A1 | PRODUCTS AND METHODS FOR THE TREATMENT OF MIXTURES OF WATER AND HYDROPHOBIC LIQUIDS | B.C. RESEARCH INC. (CA) | 2019-12-12 | — | — | WO | claimed |
| EP-0443891-B1 | USE OF N-MYRISTOYL-(S)-PHENYLALANINE FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF DISORDERS BY INHIBITING THE MYRISTOYLATION | ADIR ET COMPAGNIE (FR) | 1993-09-15 | — | — | EP | claimed |
| US-5164414-A | Antitumor | ADIR ET COMPAGNIE (FR) | 1992-11-17 | — | — | US | claimed |
| EP-0473700-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1992-03-11 | — | — | EP | claimed |
| EP-0443891-A1 | Use of N-myristoyl-(S)-phenylalanine for the preparation of a medicament for the treatment of disorders by inhibiting the myristoylation | ADIR ET COMPAGNIE (FR) | 1991-08-28 | — | — | EP | claimed |
| WO-1990014429-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1990-11-29 | — | — | WO | claimed |
| JP-4210916-A | — | — | None | — | — | JP | disclosed |
| US-20260115292-A1 | COMPOSITION COMPRISING A PROTEIN AND A POLYALKOXY FATTY ACYL SURFACTANT | NUTRITION & BIOSCIENCES USA 1 LLC (US) | 2026-04-30 | — | — | US | disclosed |
| CN-117643709-A | Antifreezing fire water evaporation-proof crystallization inhibitor and preparation method thereof | 陕西交通控股集团有限公司宜富分公司 | 2024-03-05 | — | — | CN | disclosed |
| US-20230242580-A1 | BIOPROCESS WITH REDUCED FOULING ON SURFACES | NUTRITION & BIOSCIENCES USA 1, LLC | 2023-08-03 | — | — | US | disclosed |
| CN-116348475-A | Biological process with reduced fouling on surfaces | 营养与生物科学美国1有限责任公司 | 2023-06-27 | — | — | CN | disclosed |
| JP-H04210916-A | USE OF N-MYRISTOYL-(S)-PHENYLALANINE FOR OBTAINING PRODUCT HAVING PHARMACODYNAMIC EFFECT FOR TREATMENT OF DISEASE INVOLVING MYRISTOYLATION | ADIR | 1992-08-03 | — | — | JP | disclosed |
| EP-0473700-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1992-03-11 | — | — | EP | disclosed |
| EP-0443891-A1 | Use of N-myristoyl-(S)-phenylalanine for the preparation of a medicament for the treatment of disorders by inhibiting the myristoylation | ADIR ET COMPAGNIE (FR) | 1991-08-28 | — | — | EP | disclosed |
| EP-0443891-A1 | Use of N-myristoyl-(S)-phenylalanine for the preparation of a medicament for the treatment of disorders by inhibiting the myristoylation | ADIR ET COMPAGNIE (FR) | 1991-08-28 | — | — | EP | disclosed |
| EP-0443891-A1 | Use of N-myristoyl-(S)-phenylalanine for the preparation of a medicament for the treatment of disorders by inhibiting the myristoylation | ADIR ET COMPAGNIE (FR) | 1991-08-28 | — | — | EP | disclosed |
| WO-1990014429-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1990-11-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242580-A1 | BIOPROCESS WITH REDUCED FOULING ON SURFACES | F12, F13B, F13A1 | FAAH 279/4885ITGB3 62/4885ITGA2B 290/4885 |
| US-20210230466-A1 | PRODUCTS AND METHODS FOR THE TREATMENT OF MIXTURES OF WATER AND HYDROPHOBIC LIQUIDS | SLC43A1, FABP2, FABP1 | FAAH 148/4885ITGB3 290/4885ITGA2B 244/4885 |
| US-20260115292-A1 | COMPOSITION COMPRISING A PROTEIN AND A POLYALKOXY FATTY ACYL SURFACTANT | CETP, PCTP, PLTP | FAAH 45/4885ITGB3 588/4885ITGA2B 982/4885 |
| US-11485891-B2 | Products and methods for the treatment of mixtures of water and hydrophobic liquids | SLC43A1, SLC27A1, FABP1 | FAAH 202/4885ITGB3 404/4885ITGA2B 491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.